U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774702) titled 'Psilocybin for Methamphetamine Use Disorder' on Aug. 11.
Brief Summary: This trial tests whether psilocybin-assisted treatment can help adults stop using methamphetamine. Participants receive a single oral dose of psilocybin during a supervised session, paired with brief cognitive behavioral therapy, and are followed for up to six months. The study is supported by the HEAL Initiative (https://www.nih.gov/heal).
Study Start Date: Feb. 01, 2027
Study Type: INTERVENTIONAL
Condition:
Methamphetamine Use Disorder
Intervention:
DRUG: Psilocybin (single oral capsule administered at one of two dose levels, Dose A or Dose B; specific d...